InvestorsHub Logo

wise_investor

08/18/17 7:52 PM

#5183 RE: wise_investor #5172

Mr Soon is no fool, they know this is a win win situation. Mr soon will make his money back on fear mongering, after all he is controversial.

There will ne no Reverse split. Why would they release such news on a Friday? Because this is a strategic move to make money and the MM's will lend themselves to also make money.

See my previous post.

"Under the pact, CytRx will also gain increasing double-digit royalties for sales of aldoxorubicin, should it gain approval, for STS, and mid- to high-single-digit royalties for any and all other indications. The biobucks deal could be worth over $350 million, but a lot needs to go right for that to be realized. 

NantCell will be responsible for all future development, manufacturing and commercialization expenses, it said in a brief update. CytRx has also issued NantCell a warrant to purchase up to 3 million shares of common stock, also at $1.10, over the next year and a half."

The only reason why nantcell would commit to something like that if if they knew they were going to make money on it.

One thing is for sure if I had 13 million dollars to invest I better be sure I'm going to make money on it not lose it right?

Tekterra

08/19/17 8:05 AM

#5196 RE: wise_investor #5172

Wise investor, that's what a normal company would do. Cytrx is far from normal if you really dig into all the sec filings and events that happened in the last year. Read my other post and you will understand why NantCell wants K to push RS through.